Monograph: Antituberculosis Agents General Statement

Antituberculosis Agents General Statement

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Antituberculosis Agents General Statement

Classification

General Principles in Antituberculosis Therapy

...

Latent Tuberculosis Infection versus Active Tuberculosis

...

Patient Compliance

...

Duration of Therapy

...

Patient Monitoring

...

Active Tuberculosis

...

Active Tuberculosis in Adults

...

Initial Treatment Phase

...

Continuation Treatment Phase

...

Completion of Treatment and Total Number of Doses

...

Table 1. Recommended Regimens for Culture-Positive, Drug-Susceptible Pulmonary Tuberculosis

...

Active Tuberculosis in Pediatric Patients

...

Infants and Children

...

Neonates

...

Active Tuberculosis During Pregnancy

...

Drug-Resistant Tuberculosis

...

Table 2. Potential Regimens for Management of Patients with Drug-Resistant Pulmonary Tuberculosis

...

Relapse or Treatment Failure

...

Relapse

...

Treatment Failure

...

Extrapulmonary Tuberculosis

...

Adults

...

Pediatric Patients

...

Tuberculous Meningitis

...

Adjunctive Use of Corticosteroids

...

Active Tuberculosis in HIV-Infected Individuals

...

Patients Receiving Concurrent Antiretroviral Therapy

...

Patients Not Receiving Concurrent Antiretroviral Therapy

...

Drug-Resistant Tuberculosis in HIV-Infected Individuals

...

Tuberculosis in HIV-Infected Pediatric Patients

...

Tuberculosis during Pregnancy in HIV-Infected Patients

...

Extrapulmonary Tuberculosis in HIV-infected Patients

...

Latent Tuberculosis Infection

...

Management of Other Mycobacterial Diseases

...

Susceptibility Testing

...

Mycobacterium avium Complex (MAC) Infections

...

Treatment of Pulmonary and Localized Extrapulmonary MAC Infections

...

Primary Prevention of Disseminated MAC Infection

...

Treatment and Prevention of Recurrence of Disseminated MAC Infection

...

Mycobacterium kansasii Infections

...

Mycobacterium marinum Infections

...

Mycobacterium abscessus, M. chelonae, M. fortuitum, and M. smegmatis Infections

...

Mycobacterium malmoense, M. simiae, M. szulgai, and M. xenopi

...

Leprosy

...

...

Common monograph Elements

Related Monographs

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2021, Selected Revisions January 1, 2007. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information